Within the tumour, no significant differences were observed in the number of CD4 + T cells of different treatment groups; however, there was a significant increase in the proliferating and activated CD4+ cells in mice treated with vaccine MPs as compared to the other treatment groups (Fig. S10a). This evidence concerns the gene CD4 and neoplasm.